A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

Autor: DiPeri, Timothy P., Newhook, Timothy E., Day, Ryan W., Chiang, Yi-Ju, Dewhurst, Whitney L., Arvide, Elsa M., Bruno, Morgan L., Scally, Christopher P., Roland, Christina L., Katz, Matthew H.G., Vauthey, Jean-Nicolas, Chang, George J., Badgwell, Brian D., Perrier, Nancy D., Grubbs, Elizabeth G., Lee, Jeffrey E., Tzeng, Ching-Wei D., Bednarski, Brian K., Chen, Iris B., Comeaux, Ryan J., Cox, Dana M., Feig, Barry W., Fisher, Sarah B., Fournier, Keith F., Ghebremichael, Semhar J., Gibson, Heather M., Gourmelon, Nicole C., Graham, Paul H., Hancher, Shannon, Hunt, Kelly K., Ikoma, Naruhiko, Ivey MPAS, Shanae L., Keung, Emily Z., Ledet, Celia R., Limmer, Angela R., Mansfield, Paul F., Mayon, Lauren K., Messick, Craig A., Popat, Keyuri U., Rajkot MPAS, Nikita F., Robinson MPAS, Justine L., Robinson MPAS, Kristen A., Rodriguez-Bigas, Miguel A., Santos, David A., Skibber, John M., Speer, B. Bryce, Soliz, Jose, Tillman, Matthew M., Torres, Keila E., van Meter, Antoinette, Weldon, Marla E., Williams, Uduak Ursula, You, Y. Nancy
Zdroj: Surgery Open Science; July 2022, Vol. 9 Issue: 1 p51-57, 7p
Abstrakt: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care.
Databáze: Supplemental Index